A Brief Questionnaire on Healthcare Workers’ Awareness Toward the COVID-19 Vaccine and Antibody Tests

IF 0.7 Q4 GEOSCIENCES, MULTIDISCIPLINARY Journal of Disaster Research Pub Date : 2023-01-20 DOI:10.20965/jdr.2023.p0021
N. Shimasaki, Junko Ishii, Tomoko Kuwahara, Haruna Nishijima
{"title":"A Brief Questionnaire on Healthcare Workers’ Awareness Toward the COVID-19 Vaccine and Antibody Tests","authors":"N. Shimasaki, Junko Ishii, Tomoko Kuwahara, Haruna Nishijima","doi":"10.20965/jdr.2023.p0021","DOIUrl":null,"url":null,"abstract":"In 2022, the coronavirus disease 2019 (COVID-19) continues to spread worldwide with the emergence of many variants. Healthcare workers (HCWs) are encouraged to be vaccinated against COVID-19 because vaccines provide powerful protection from serious illnesses, hospitalization, and death. However, breakthrough infections on vaccinees have been frequently reported, and more studies are required to understand the mechanism of breakthrough infection and establish a standard neutralizing antibody (NTAb) level with efficacy. In particular, it is important to develop useful research tools for HCWs at high risk of breakthrough infection. Here, we administered a brief questionnaire on awareness of COVID-19 vaccines and antibody tests to uncover the needs of HCWs. Our questionnaire showed that HCWs felt a lower priority for vaccines among infection control measures than non-HCWs. On the other hand, HCWs expected more strongly the vaccine to be effective in preventing infection at work than non-HCWs. About half of the respondents, whether HCWs or not, thought that there was a correlation between the severity of adverse reactions and the degree of antibody induction. About 20% of the respondents had a change in awareness of the correlation after an antibody survey. Many respondents believed that the antibody test would be useful. Therefore, we should contribute to the development of a method of evaluating vaccines that can protect against infection and to improving other infection control measures in the future.","PeriodicalId":46831,"journal":{"name":"Journal of Disaster Research","volume":" ","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Disaster Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20965/jdr.2023.p0021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GEOSCIENCES, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

In 2022, the coronavirus disease 2019 (COVID-19) continues to spread worldwide with the emergence of many variants. Healthcare workers (HCWs) are encouraged to be vaccinated against COVID-19 because vaccines provide powerful protection from serious illnesses, hospitalization, and death. However, breakthrough infections on vaccinees have been frequently reported, and more studies are required to understand the mechanism of breakthrough infection and establish a standard neutralizing antibody (NTAb) level with efficacy. In particular, it is important to develop useful research tools for HCWs at high risk of breakthrough infection. Here, we administered a brief questionnaire on awareness of COVID-19 vaccines and antibody tests to uncover the needs of HCWs. Our questionnaire showed that HCWs felt a lower priority for vaccines among infection control measures than non-HCWs. On the other hand, HCWs expected more strongly the vaccine to be effective in preventing infection at work than non-HCWs. About half of the respondents, whether HCWs or not, thought that there was a correlation between the severity of adverse reactions and the degree of antibody induction. About 20% of the respondents had a change in awareness of the correlation after an antibody survey. Many respondents believed that the antibody test would be useful. Therefore, we should contribute to the development of a method of evaluating vaccines that can protect against infection and to improving other infection control measures in the future.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医护人员对新冠肺炎疫苗和抗体检测的认识简表
2022年,2019冠状病毒病(新冠肺炎)继续在全球传播,出现了许多变种。鼓励医护人员(HCW)接种新冠肺炎疫苗,因为疫苗对严重疾病、住院和死亡提供了强有力的保护。然而,疫苗接种者的突破性感染经常被报道,需要更多的研究来了解突破性感染的机制,并建立具有疗效的标准中和抗体(NTAb)水平。特别重要的是,为突破性感染风险高的HCW开发有用的研究工具。在这里,我们对新冠肺炎疫苗的认识和抗体测试进行了简短的问卷调查,以揭示HCW的需求。我们的问卷调查显示,在感染控制措施中,HCW认为疫苗的优先顺序低于非HCW。另一方面,HCW比非HCW更强烈地期望疫苗在预防工作中感染方面更有效。大约一半的受访者,无论是否为HCW,都认为不良反应的严重程度与抗体诱导程度之间存在相关性。大约20%的受访者在抗体调查后对相关性的认识发生了变化。许多受访者认为抗体测试是有用的。因此,我们应该为开发一种评估疫苗的方法做出贡献,这种疫苗可以预防感染,并在未来改进其他感染控制措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Disaster Research
Journal of Disaster Research GEOSCIENCES, MULTIDISCIPLINARY-
CiteScore
1.60
自引率
37.50%
发文量
113
期刊最新文献
Impact Resistance Test of Cladding by Using Gravel Applicability of a Modified I-D Method for Predicting Slope Failure to Different Slopes Disaster Preparedness Using Local Wisdom Approach in Palu City Stochastic Precipitation Model Using Large Ensemble Data Estimation of the Seismic Source of the 1974 Lima Peru Earthquake and Tsunami (Mw 8.1)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1